CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device ...

The human leukocyte antigen (HLA) system has an important role in the regulation of the immune system; the HLA recognizes cells as ‘non-self’ or ‘self’ to prevent the body from attacking its own cells ...

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted de novo classification to the SeCore CDx HLA Sequencing System for use as a companion diagnostic ...

Effect of an Invitation or the Effect of Participation: What Should Randomized Controlled Trials of Cancer Screening Examine? In two articles that accompany this editorial, 9,10 the potential of ...

CDNA unveils AlloSeq Nano, delivering high-resolution HLA typing in under 3 hours, aiming to boost transplant diagnostics ...

Rates of HLA-B*58:01 allele testing were markedly higher with use of a clinician-facing dashboard plus a best practice alert vs a dashboard alone in patients prescribed allopurinol. Implementation of ...